Apellis Pharmaceuticals' Unattributed Round

Apellis Pharmaceuticals raised a round of funding on May 21, 2010.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company, focused on the development of a platform of novel therapeutic compounds for the treatment of a broad range of autoimmune diseases…

Articles about Apellis Pharmaceuticals' Unattributed Round: